We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+7.04%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.37B
AUM Growth
+$62.8M
(+1.2%)
Cap. Flow
-$112M
Cap. Flow
% of AUM
-2.09%
Top 10 Holdings %
Top 10 Hldgs %
20.35%
Holding
855
New
121
Increased
189
Reduced
310
Closed
120
Avg Time Held
1
year
Top 10 Avg Time Held
0.6
years
Top 20 Avg Time Held
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$45.7M |
| 2 |
Idexx Laboratories
IDXX
|
+$34.3M |
| 3 |
Cardinal Health
CAH
|
+$30.2M |
| 4 |
Applied Materials
AMAT
|
+$24.5M |
| 5 |
Elevance Health
ELV
|
+$24.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$73.1M |
| 2 |
Dover
DOV
|
+$41.7M |
| 3 |
SLB Ltd
SLB
|
+$40M |
| 4 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$38.2M |
| 5 |
Wynn Resorts
WYNN
|
+$35.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.73% |
| 2 | Financials | 15.53% |
| 3 | Industrials | 13.23% |
| 4 | Consumer Discretionary | 12.83% |
| 5 | Technology | 10.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SVLC
551
DELISTED
SILVERCREST MINES INC ORD SHS (CDA)
SVLC
| $109K | ﹤0.01% |
86,000
-4,000
| -4% | -$5.41K |
2013 Q2
6 quarters
|
|
|
FTR
552
DELISTED
Frontier Communications Corp.
FTR
| $105K | ﹤0.01% |
1,045
-46
| -4% | -$4.51K |
2014 Q1
3 quarters
|
|
553
Wendy's
WEN
$1.28B
| $92K | ﹤0.01% |
10,165
| – | – |
2014 Q3
1 quarter
|
|
|
GPIC
554
DELISTED
Gaming Partners International Corporation
GPIC
| $89K | ﹤0.01% |
1,111,775
-20,000
| -2% | -$166K |
2013 Q2
6 quarters
|
|
555
DELISTED
BLUE EARTH, INC. COMMON STOCK
BBLU
| $80K | ﹤0.01% |
74,000
-4,480
| -6% | -$7.1K |
2014 Q3
1 quarter
|
|
556
MannKind Corp
MNKD
$1.03B
| $78K | ﹤0.01% |
3,004
-1,600
| -35% | -$45.2K |
2014 Q3
1 quarter
|
|
557
SiriusXM
SIRI
$9.15B
| $76K | ﹤0.01% |
2,163
-110
| -5% | -$3.79K |
2013 Q2
6 quarters
|
|
|
PLM
558
DELISTED
PolyMet Mining Corp.
PLM
| $73K | ﹤0.01% |
6,980
| – | – |
2013 Q2
6 quarters
|
|
|
ELI
559
DELISTED
ELITE PHARMACEUTICAL
ELI
| $66K | ﹤0.01% |
290,880
| – | – |
2013 Q2
6 quarters
|
|
|
MDW
560
DELISTED
MIDWAY GOLD CORP (CANADA)
MDW
| $62K | ﹤0.01% |
84,100
| – | – |
2013 Q2
6 quarters
|
|
561
Kamada
KMDA
$452M
| $53K | ﹤0.01% |
14,000
+2,700
| +24% | +$10.2K |
2014 Q3
1 quarter
|
|
562
UBS Asset Management Income Fund, Inc.
CIK
$126M
| $51K | ﹤0.01% |
+15,504
| New | +$52K |
2014 Q4
0 quarters
|
|
563
Fortuna Silver Mines
FSM
$3.12B
| $46K | ﹤0.01% |
10,000
| – | – |
2013 Q2
6 quarters
|
|
|
EXXI
564
DELISTED
ENERGY XXI LTD COM SHS
EXXI
| $34K | ﹤0.01% |
+10,380
| New | +$63.3K |
2014 Q4
0 quarters
|
|
|
ECT
565
DELISTED
ECA Marcellus Trust 1 Interest
ECT
| $33K | ﹤0.01% |
10,600
-1,600
| -13% | -$7.14K |
2014 Q3
1 quarter
|
|
566
DELISTED
BKF CAPITAL GROUP,INC
BKF
| $25K | ﹤0.01% |
17,000
| – | – |
2013 Q2
6 quarters
|
|
|
EOX
567
DELISTED
EMERALD OIL INC (MT)
EOX
| $24K | ﹤0.01% |
+1,000
| New | +$54.3K |
2014 Q4
0 quarters
|
|
568
Denison Mines
DNN
$2.14B
| $23K | ﹤0.01% |
25,000
| – | – |
2013 Q2
6 quarters
|
|
569
DELISTED
AMERICAN EAGLE ENERGY CORP NEW COM STK (NV)
AMZG
| $16K | ﹤0.01% |
25,150
| – | – |
2013 Q4
4 quarters
|
|
|
GMO
570
DELISTED
General Moly, Inc.
GMO
| $8K | ﹤0.01% |
13,518
| – | – |
2013 Q2
6 quarters
|
|
|
QMM
571
DELISTED
QUATERRA RESOURCES INC LTD
QMM
| $5K | ﹤0.01% |
136,175
| – | – |
2013 Q2
6 quarters
|
|
|
ISV
572
DELISTED
INSITE VISION,INC.
ISV
| $3K | ﹤0.01% |
14,799
| – | – |
2013 Q2
6 quarters
|
|
573
Alterity Therapeutics
ATHE
$49.5M
| – | – |
-184
| Closed | -$24K | – |
|
574
ATI
ATI
$25.8B
| – | – |
-13,925
| Closed | -$517K | – |
|
575
American Water Works
AWK
$26.4B
| – | – |
-4,315
| Closed | -$208K | – |
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q4 2014 Portfolio in Review
As of Q4 2014, Geneva Advisors held 855 positions worth $5.37B, up 1.2% from $5.31B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Geneva Advisors's Q4 2014 filing shows 121 new, 189 increased, 310 reduced and 120 closed positions. Its largest new stake was Idexx Laboratories: 488,650 shares worth $36.2M. The largest sale was LyondellBasell Industries, an estimated $73.1M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.
- Geneva Advisors's largest Q4 2014 buy was Idexx Laboratories: 488,650 shares worth $36.2M.
- Geneva Advisors added most to Alibaba in Q4 2014, an estimated $45.7M increase.
- Geneva Advisors's biggest Q4 2014 reduction was LyondellBasell Industries, cutting an estimated $73.1M.
- Geneva Advisors fully exited Community Health Systems in Q4 2014, selling an estimated $13M.
- Geneva Advisors's ten largest holdings make up 20% of its $5.37B portfolio in Q4 2014.
- Geneva Advisors opened 121 new positions and closed 120 in Q4 2014.
- Geneva Advisors's portfolio value rose 1.2% quarter-over-quarter to $5.37B.
Based on Geneva Advisors's 13F filing for Q4 2014, filed 2 Feb 2015.